Literature DB >> 11819863

p16 gene methylation in colorectal cancers associated with Duke's staging.

J Yi1, Z W Wang, H Cang, Y Y Chen, R Zhao, B M Yu, X M Tang.   

Abstract

AIM: To explore the association of methylation of the CpG island in the promotor of the p16 tumor suppressor gene with the clinicopathological characteristics of the colorectal cancers.
METHODS: Methylation-specific PCR (MSP) was used to detect p16 methylation of 62 sporadic colorectal cancer specimens.
RESULTS: p16 methylation was detected in 42% of the tumors.Dukes'staging was associated with p16 methylation status.p16 methylation occurred more frequently in Dukes'C and D patients (75.9%) than in Dukes'A and B patients (12.1%).
CONCLUSION: p16 methylation plays a role in the carcinogenesis of a subset of colorectal cancer, and it might be linked to poor prognosis.

Entities:  

Mesh:

Year:  2001        PMID: 11819863      PMCID: PMC4695583          DOI: 10.3748/wjg.v7.i5.722

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  43 in total

Review 1.  Gene silencing in the development of cancer.

Authors:  M W McBurney
Journal:  Exp Cell Res       Date:  1999-04-10       Impact factor: 3.905

2.  Hypermethylation of p16 and p15 genes and RB protein expression in acute leukemia.

Authors:  S X Guo; T Taki; H Ohnishi; H Y Piao; K Tabuchi; F Bessho; R Hanada; M Yanagisawa; Y Hayashi
Journal:  Leuk Res       Date:  2000-01       Impact factor: 3.156

3.  Gene promoter hypermethylation in tumors and serum of head and neck cancer patients.

Authors:  M Sanchez-Cespedes; M Esteller; L Wu; H Nawroz-Danish; G H Yoo; W M Koch; J Jen; J G Herman; D Sidransky
Journal:  Cancer Res       Date:  2000-02-15       Impact factor: 12.701

4.  Methylation status of p16 gene in colorectal carcinoma and normal colonic mucosa.

Authors:  Jing Zhang; Mao-De Lai; Jian Chen
Journal:  World J Gastroenterol       Date:  1999-10       Impact factor: 5.742

5.  CpG island hypermethylation in human colorectal tumors is not associated with DNA methyltransferase overexpression.

Authors:  C A Eads; K D Danenberg; K Kawakami; L B Saltz; P V Danenberg; P W Laird
Journal:  Cancer Res       Date:  1999-05-15       Impact factor: 12.701

6.  CpG island methylator phenotype in colorectal cancer.

Authors:  M Toyota; N Ahuja; M Ohe-Toyota; J G Herman; S B Baylin; J P Issa
Journal:  Proc Natl Acad Sci U S A       Date:  1999-07-20       Impact factor: 11.205

7.  DNA methylation and genetic instability in colorectal cancer cells.

Authors:  C Lengauer; K W Kinzler; B Vogelstein
Journal:  Proc Natl Acad Sci U S A       Date:  1997-03-18       Impact factor: 11.205

8.  Frequent hypermethylation of p16 and p15 genes in multiple myeloma.

Authors:  M H Ng; Y F Chung; K W Lo; N W Wickham; J C Lee; D P Huang
Journal:  Blood       Date:  1997-04-01       Impact factor: 22.113

9.  p16(INK4) is inactivated by extensive CpG methylation in human hepatocellular carcinoma.

Authors:  Y Matsuda; T Ichida; J Matsuzawa; K Sugimura; H Asakura
Journal:  Gastroenterology       Date:  1999-02       Impact factor: 22.682

10.  Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands.

Authors:  J G Herman; J R Graff; S Myöhänen; B D Nelkin; S B Baylin
Journal:  Proc Natl Acad Sci U S A       Date:  1996-09-03       Impact factor: 11.205

View more
  14 in total

1.  Prognostic significance of regulators of cell cycle and apoptosis, p16(INK4a), p53, and bcl-2 in primary mucosal melanomas of the head and neck.

Authors:  Manju L Prasad; Snehal G Patel; Jatin P Shah; Stacy Hoshaw-Woodard; Klaus J Busam
Journal:  Head Neck Pathol       Date:  2011-12-13

2.  Aberrant promoter methylation of p16 in colorectal adenocarcinoma in North Indian patients.

Authors:  Pooja Malhotra; Rakesh Kochhar; Kim Vaiphei; Jai Dev Wig; Safrun Mahmood
Journal:  World J Gastrointest Oncol       Date:  2010-07-15

3.  Aberrant Promoter Hypermethylation of p16 and RASSF1a Genes in Colorectal Cancer - Significance in Young Patients.

Authors:  Medha Sugara; Ramachandra Chowdappa; K V Veerendra Kumar; Ramesh Gawari; Shalini N Swamy; Sandeep S Kumar
Journal:  Indian J Surg Oncol       Date:  2021-04-24

4.  Arterial chemotherapy of 5-fluorouracil and mitomycin C in the treatment of liver metastases of colorectal cancer.

Authors:  Lian-Xin Liu; Wei-Hui Zhang; Hong-Chi Jiang; An-Long Zhu; Lin-Feng Wu; Shu-Yi Qi; Da-Xun Piao
Journal:  World J Gastroenterol       Date:  2002-08       Impact factor: 5.742

5.  Aberrant p16((INK4a)) methylation is a frequent event in colorectal cancers: prognostic value and relation to mRNA expression and immunoreactivity.

Authors:  Hiroyuki Mitomi; Naoshi Fukui; Nobuho Tanaka; Hideki Kanazawa; Tsuyoshi Saito; Takashi Matsuoka; Takashi Yao
Journal:  J Cancer Res Clin Oncol       Date:  2010-02       Impact factor: 4.553

6.  Prognostic factors in 165 elderly colorectal cancer patients.

Authors:  Ke-Jun Nan; Hai-Xia Qin; Guang Yang
Journal:  World J Gastroenterol       Date:  2003-10       Impact factor: 5.742

7.  Comethylation of p16 and MGMT genes in colorectal carcinoma: correlation with clinicopathological features and prognostic value.

Authors:  Koviljka Krtolica; Milena Krajnovic; Slavica Usaj-Knezevic; Dragan Babic; Dusan Jovanovic; Bogomir Dimitrijevic
Journal:  World J Gastroenterol       Date:  2007-02-28       Impact factor: 5.742

8.  Methylation and mutation analysis of p16 gene in gastric cancer.

Authors:  Yi Ding; Xiao-Ping Le; Qin-Xian Zhang; Peng Du
Journal:  World J Gastroenterol       Date:  2003-03       Impact factor: 5.742

9.  Effects of p16 gene on biological behaviours in hepatocellular carcinoma cells.

Authors:  Jian-Zhao Huang; Sui-Sheng Xia; Qi-Fa Ye; Han-Ying Jiang; Zhong-Hua Chen
Journal:  World J Gastroenterol       Date:  2003-01       Impact factor: 5.742

10.  The blues of P(16)INK(4a): aberrant promoter methylation and association with colorectal cancer in the Kashmir valley.

Authors:  A Syed Sameer; Safiya Abdullah; Saniya Nissar; Roohi Rasool; Zaffar A Shah; Dil Afroze; Nissar A Chowdri; Mushtaq A Siddiqi
Journal:  Mol Med Rep       Date:  2012-01-03       Impact factor: 2.952

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.